TrademarkDir
PRODUCT INNOVATION. PATIENT IMPACT.
DEAD

Serial Number

86398952

Owner

Concert Pharmaceuticals, Inc.

Attorney

Patrick J. Concannon

Filing Date

Sep 18, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PRODUCT INNOVATION. PATIENT IMPACT. Trademark

Serial Number: 86398952

PRODUCT INNOVATION. PATIENT IMPACT. is a trademark filed by Concert Pharmaceuticals, Inc. on September 18, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Concert Pharmaceuticals, Inc. (21 trademarks)

65 Hayden Avenue, Suite 3000N
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

September 18, 2014

Registration Date

Not Registered

Published for Opposition

August 4, 2015

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 5, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 5, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2018 EXRA
SOU EXTENSION 5 GRANTED
Mar 31, 2018 EX5G
SOU EXTENSION 5 FILED
Mar 29, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 29, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2017 EXRA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2017 TCCA
SOU EXTENSION 4 GRANTED
Sep 22, 2017 EX4G
SOU EXTENSION 4 FILED
Sep 22, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 22, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2017 EXRA
SOU EXTENSION 3 GRANTED
Mar 27, 2017 EX3G
SOU EXTENSION 3 FILED
Mar 27, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 27, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 18, 2016 EXRA
SOU EXTENSION 2 GRANTED
Oct 15, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 13, 2016 AITU
SOU EXTENSION 2 FILED
Sep 21, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 21, 2016 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 21, 2016 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2016 EXRA
SOU EXTENSION 1 GRANTED
Mar 8, 2016 EX1G
SOU EXTENSION 1 FILED
Mar 8, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 8, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 29, 2015 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2015 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 4, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 4, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 30, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 26, 2015 CRFA
ASSIGNED TO LIE
Jun 26, 2015 ALIE
ASSIGNED TO LIE
Jun 16, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2015 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 6, 2015 GPRN
PRIORITY ACTION E-MAILED
Jan 6, 2015 GPRA
PRIORITY ACTION WRITTEN
Jan 6, 2015 CPRA
ASSIGNED TO EXAMINER
Jan 2, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2014 NWOS
NEW APPLICATION ENTERED
Sep 22, 2014 NWAP

Related Trademarks

More from this Owner

CONCERT PHARMACEUTICALS INC. logo

CONCERT PHARMACEUTICALS INC.

PRODUCT INNOVATION. PATIENT IMPACT.

PRODUCT INNOVATION. PATIENT IMPACT.

CONCERT PHARMACEUTICALS INC.

CONCERT PHARMACEUTICALS INC.

LEQSELVI

LEQSELVI

LEQSELVI

LEQSELVI

RENZYNCE

RENZYNCE